Exposing hidden targets within the mRNA regulation space

The process of mRNA regulation is an intricate one, involving various levels of control to ensure the proper synthesis of proteins. Energy-intensive mRNA translation is tightly regulated at multiple post-transcription levels, including splicing, nuclear export, intracellular localization, degradation, stabilization, and translation, to ensure that proteins are produced only when and where needed. A deeper understanding of the regulatory mechanisms that oversee mRNA translation can uncover new targets for drug discovery and therapeutic intervention.

The following webinar features Iris Alroy, Co-Founder and Chief Scientific Officer at Anima Biotech, a leading drug discovery platform company in the field of mRNA biology, and Michael Kharas, a world-renowned cancer biologist and expert in RNA regulation from Memorial Sloan Kettering Cancer Center. Iris and Michael discuss the latest advancements in mRNA regulation research and the impact of these findings on drug discovery.


Fill out this form to get immediate access to the webinar video and white paper

By registering for this event, you accept that you may receive direct communication from Anima.